has received approval to market its “Spider Surgical System” in the Europe Union.
The decision, which the company announced Thursday, follows approval in the U.S.
TransEnterix, a venture-backed firm that has raised more than $70 million in backing, launched the minimally invasive Spider system in March.
A year ago, TransEnterix raised $55 million in funding. Among the investors is Durham-based Intersouth Partners.
Surgeons utilize the Spider for abdominal surgery. A small incision is made in a patient’s belly button and the surgeon manipulates the device into position where it is opened like an umbrella.
TransEnterix noted that a surgeon in Austria recently used the Spider for two gallbladder operations as well as a procedure to repair a hernia and to perform a colorectal procedure.
Surgeons have also used the Spider system for kidney removal, to apply gastric bands and to treat colon cancer.
Get the latest news alerts: at Twitter.